Skip to main content

Advertisement

Log in

Benefits of the tranexamic acid in head trauma with no extracranial bleeding: a prospective follow-up of 180 patients

  • Original Paper
  • Published:
European Journal of Trauma and Emergency Surgery Aims and scope Submit manuscript

Abstract

Introduction

Tranexamic acid (TXA) is one of the debated therapies in the management of traumatic brain injury (TBI). We conducted this study to evaluate the benefits of TXA in TBI on the mortality and its safety in these patients.

Methods

This was a prospective randomized open-label trial including all patients, aged at 18 years or older, hospitalized in the emergency room during a 13-month period, for TBI. After the realization of the body CT scan, the patients were included if they had intracranial bleeding, and were then randomized according to their medical file number to receive or not the TXA. The eligibility criteria were based on the uncertainty principle, patients with significant extracranial bleeding were excluded since there was evidence that TXA improve their outcome.

Results

We enrolled 180 patients aged at 42 ± 20 years, with an 88% men-proportion. Subarachnoid haemorrhage was the most frequent lesion in the brain CT-scan (67.5%). After randomization, 96 patients were in the TXA group (53%). Demographic data, clinical, biological and radiological features were statistically comparable in the two groups of patients (‘TXA’ and ‘noTXA’). The needs of transfusion or neurosurgery, the mortality rate, the in-hospital length of stay and the dependency at 28-post-traumatic day were similar in the two groups of patients. However, pulmonary embolism was statistically more frequent in ‘TXA’ group (11.5 versus 2.4%, p = 0.02).

Conclusion

TXA is an interesting treatment in haemorrhagic shock. Its efficiency in head trauma is still debated and controversial. Its impact on the mortality and the needs of transfusion or surgery were not demonstrated in this study. Nevertheless, its safety worth to be studied in larger samples as we found a higher rate of pulmonary embolism in the treated group.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Chelly H, Bahloul M, Ammar R, et al. Clinical characteristics and prognosis of traumatic head injury following road traffic accidents admitted in ICU “analysis of 694 cases”. Eur J Trauma Emerg Surg. 2017. https://doi.org/10.1007/s00068-017-0885-4 (Epub ahead of print).

    Article  PubMed  Google Scholar 

  2. Bahloul M, Chelly H, Ben Hmida M, et al. Prognosis of traumatic head injury in South Tunisia: a multivariate analysis of 437 cases. J Trauma. 2004;57:255–61.

    Article  PubMed  Google Scholar 

  3. Jackisch J, Sethi D, Mitis F, et al. European facts and the Global status report on road safety. 2015; (WHO 2015). http://www.euro.who.int/__data/assets/pdf_file/0006/293082/European-facts-Global-Status-Report-road-safety-en.pdf. Accessed 15 June 2018.

  4. Peeters W, van den Brande R, Polinder S, et al. Epidemiology of traumatic brain injury in Europe. Acta Neurochir (Wien). 2015;157:1683–96. https://doi.org/10.1007/s00701-015-2512-7.

    Article  Google Scholar 

  5. Boudreau R, Johnson M, Veile R, et al. Impact of tranexamic acid on coagulation and inflammation in murine models of traumatic brain injury and hemorrhage. J Surg Res. 2017;215:47–54. https://doi.org/10.1016/j.jss.2017.03.031.

    Article  CAS  PubMed  Google Scholar 

  6. CRASH-2 trial collaborators, Shakur H, Roberts I, Bautista R, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010; 376 (9734): 23–32. https://doi.org/10.1016/S0140-6736(10)60835-5.

    Article  CAS  Google Scholar 

  7. Roberts I. Shakur H, Coats T, et al. The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. Health Technol Assess. 2013;17(10):1–79. https://doi.org/10.3310/hta17100.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. CRASH-2 trial collaborators, Roberts I, Shakur H, Afolabi A, et al. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet 2011;377(9771):1096–101. https://doi.org/10.1016/S0140-6736(11)60278-X (1101 e1091-2)

    Article  CAS  Google Scholar 

  9. Majima N, Nishihara I, Yamaguchi K, et al. Usefulness of tranexamic acid in patients with severe head injury. Masui. 2013;62:410–5 (PMID: 23697191).

    PubMed  Google Scholar 

  10. Mahmood A, Roberts I, Shakur H. A nested mechanistic sub-study into the effect of tranexamic acid versus placebo on intracranial haemorrhage and cerebral ischaemia in isolated traumatic brain injury: study protocol for a randomised controlled trial (CRASH-3 Trial Intracranial Bleeding Mechanistic Sub-Study [CRASH-3 IBMS]). Trials. 2017;18:330. https://doi.org/10.1186/s13063-017-2073-6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Mahmood A, Roberts I, Shakur H. Does tranexamic acid improve outcomes in traumatic brain injury? BMJ. 2016;354:i4814. https://doi.org/10.1136/bmj.i4814.

    Article  PubMed  Google Scholar 

  12. Morrison JJ, Dubose JJ, Rasmussen TE, et al. Military application of tranexamic acid in trauma emergency resuscitation (MATTERs) study. Arch Surg. 2012;147:113–9. https://doi.org/10.1001/archsurg.2011.287.

    Article  CAS  PubMed  Google Scholar 

  13. Dewan Y, Komolafe EO, Mejia-Mantilla JH, et al. CRASH-3-tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trial. Trials. 2012;13:87. https://doi.org/10.1186/1745-6215-13-87.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Napolitano LM, Cohen MJ, Cotton BA, et al. Tranexamic acid in trauma. J Trauma Acute Care Surg. 2013;74:1575–86. https://doi.org/10.1097/TA.0b013e318292cc54.

    Article  PubMed  Google Scholar 

  15. Yutthakasemsunt S, Kittiwatanagul W, Piyavechvirat P, et al. Tranexamic acid for patients with traumatic brain injury: a randomized, double-blinded, placebo-controlled trial. BMC Emerg Med. 2013;13:20. https://doi.org/10.1186/1471-227X-13-20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Perel P, Al-Shahi Salman R, Kawahara T, Morris Z, Prieto-Merino D, Roberts I, et al. CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage) intracranial bleeding study: the effect of tranexamic acid in traumatic brain injury a nested randomised, placebo-controlled trial. Health Technol Assess. 2012;16(13):iii–xii. https://doi.org/10.3310/hta16130 (1–54).

    Article  CAS  PubMed  Google Scholar 

  17. Gayet-Ageron A, Prieto-Merino D, Ker K,et al. Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40138 bleeding patients. Lancet. 2018;391(10116):125–32. https://doi.org/10.1016/S0140-6736(17)32455-8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Ker K, Roberts I, Shakur H, Coats TJ. Antifibrinolytic drugs for acute traumatic injury (Review). Cochrane Database Syst Rev. 2015;9:CD004896. https://doi.org/10.1002/14651858.CD004896.pub4.

    Article  Google Scholar 

  19. Roberts I. Tranexamic acid in trauma: how should we use it? J Thromb Haemost. 2015;13(Suppl 1):S195–9. https://doi.org/10.1111/jth.12878.

    Article  CAS  PubMed  Google Scholar 

  20. Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet. 1975;1(7905):480–4.

    Article  CAS  PubMed  Google Scholar 

  21. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143(1):29–36.

    Article  CAS  PubMed  Google Scholar 

  22. Nakae R, Takayama Y, Kuwamoto K, et al. Time course of coagulation and fibrinolytic parameters in patients with traumatic brain injury. J Neurotrauma. 2016;33(7):688–95. https://doi.org/10.1089/neu.2015.4039.

    Article  PubMed  Google Scholar 

  23. Harhangi BS, Kompanje EJO, Leebeek FWG, et al. Coagulation disorders after traumatic brain injury. Acta Neurochir (Wien). 2008;150:165–75. https://doi.org/10.1007/s00701-007-1475-8.

    Article  CAS  Google Scholar 

  24. CRASH-2 Collaborators. Intracranial Bleeding Study. Effect of tranexamic acid in traumatic brain injury: a nested randomised, placebo controlled trial (CRASH-2 Intracranial Bleeding Study). BMJ. 2011;343:d3795. https://doi.org/10.1136/bmj.d3795.

    Article  Google Scholar 

  25. French KF, White J, Hoesch RE. Treatment of intracerebral hemorrhage with tranexamic acid after thrombolysis with tissue plasminogen activator. Neurocrit Care. 2012;17(1):107–11. https://doi.org/10.1007/s12028-012-9681-5.

    Article  CAS  PubMed  Google Scholar 

  26. Zehtabchi S, Abdel Baki SG, Falzon L, et al. Tranexamic acid for traumatic brain injury: a systematic review and meta-analysis. Am J Emerg Med. 2014;32:1503–9. https://doi.org/10.1016/j.ajem.2014.09.023.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Fakharian E, Abedzadeh-kalahroudi M, Atoof F. Effect of tranexamic acid on prevention of hemorrhagic mass growth in patients with traumatic brain injury. World Neurosurg. 2018;109:e748–53. https://doi.org/10.1016/j.wneu.2017.10.075.

    Article  PubMed  Google Scholar 

  28. Valle EJ, Allen CJ, Van Haren RM, et al. Do all trauma patients benefit from tranexamic acid? J Trauma Acute Care Surg. 2014;76:1373–8. https://doi.org/10.1097/TA.0000000000000242.

    Article  CAS  PubMed  Google Scholar 

  29. Jokar A, Ahmadi K, Salehi T, et al. The effect of tranexamic acid in traumatic brain injury: a randomized controlled trial. Chin J Traumatol. 2017;20(1):49–51. https://doi.org/10.1016/j.cjtee.2016.02.005.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Roberts I, Edwards P, Joshi M, et al. Tranexamic acid in bleeding trauma patients: an exploration of benefits and harms. Trials. 2017;18:48. https://doi.org/10.1186/s13063-016-1750-1.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Ker K, Roberts I, Shakur H, et al. Antifibrinolytic drugs for acute traumatic injury (Review). Cochrane Database Syst Rev. 2015;9:CD004896. https://doi.org/10.1002/14651858.CD004896.pub4.

    Article  Google Scholar 

  32. Schöchl H, Schlimp CJ, Maegele M. Tranexamic acid, fibrinogen concentrate, and prothrombin complex concentrate: data to support prehospital use? Shock. 2014;41(Suppl 1):44–6. https://doi.org/10.1097/SHK.0000000000000093.

    Article  CAS  PubMed  Google Scholar 

  33. Kageyama H, Toyooka T, Tsuzuki N, Oka K. Nonsurgical treatment of chronic subdural hematoma with tranexamic acid. J Neurosurg. 2013;119(2):332–7. https://doi.org/10.3171/2013.3.JNS122162.

    Article  PubMed  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

Authors

Contributions

Study concept and design (OCW, KCH); acquisition of the data (AS, AT, JM, AN, HK, BS); analysis of the data (OCW); drafting of the manuscript (OCW, AS, AN); critical revision of the manuscript (OCW, MB, NR); approval of final manuscript (OCW, NR).

Corresponding author

Correspondence to Olfa Chakroun-Walha.

Ethics declarations

Conflict of interest

Olfa Chakroun-Walha, Amal Samet, Mouna Jerbi, Abdennour Nasri, Aziza Talbi, Hassen Kanoun, Basma Souissi, Kamilia Chtara, Mounir Bouaziz, Hichem Ksibi and Noureddine Rekik declare that they have no competing interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chakroun-Walha, O., Samet, A., Jerbi, M. et al. Benefits of the tranexamic acid in head trauma with no extracranial bleeding: a prospective follow-up of 180 patients. Eur J Trauma Emerg Surg 45, 719–726 (2019). https://doi.org/10.1007/s00068-018-0974-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00068-018-0974-z

Keywords

Navigation